Amiral Gestion Has $11.21 Million Stock Holdings in Colgate-Palmolive Company $CL

Amiral Gestion grew its position in shares of Colgate-Palmolive Company (NYSE:CL) by 575.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 141,873 shares of the company’s stock after purchasing an additional 120,873 shares during the period. Colgate-Palmolive comprises about 4.1% of Amiral Gestion’s holdings, making the stock its 9th largest holding. Amiral Gestion’s holdings in Colgate-Palmolive were worth $11,211,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. ProShare Advisors LLC grew its holdings in Colgate-Palmolive by 11.0% in the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after acquiring an additional 202,379 shares during the last quarter. Providence Capital Advisors LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at about $5,373,000. Asset Management One Co. Ltd. boosted its holdings in shares of Colgate-Palmolive by 3.9% during the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after purchasing an additional 16,017 shares during the period. Citigroup Inc. raised its position in Colgate-Palmolive by 43.7% during the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock valued at $107,646,000 after purchasing an additional 409,710 shares during the last quarter. Finally, TD Waterhouse Canada Inc. grew its position in shares of Colgate-Palmolive by 248.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after buying an additional 62,327 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CL. Argus restated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Jefferies Financial Group upped their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Finally, Citigroup upped their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $84.25 on Friday. The stock has a market cap of $67.59 billion, a P/E ratio of 32.16, a P/E/G ratio of 3.77 and a beta of 0.28. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The stock’s fifty day moving average is $91.11 and its 200 day moving average is $83.38. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.91 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s payout ratio is presently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.